5+ hour, 10+ min ago  (440+ words) Organizations that benefit most from AI in R&D will be those that align technology with scientific reality For much of the past two years, life sciences R&D has been described as an obvious beneficiary of advances in generative…...

4+ day, 11+ hour ago  (355+ words) Why therapies still take years to reach the patients who need them A drug can clear every hurdle, including discovery, trials, regulatory approval, and still take years to reach the patients it was designed for. Not because supply chains fail…...

6+ day, 7+ hour ago  (1469+ words) Corporate compliance isn't just about avoiding fines; it's an opportunity to shape culture, partnerships, and everyday decision-making In today's world with rising legal complexity and expectations from customers, companies must go further and consider issues such as sustainability and human…...

1+ week, 5+ hour ago  (113+ words) Membrane proteins remain among the most valuable yet difficult to obtain drug targets. These proteins are notoriously challenging to express and purify in sufficient quantity and quality for structural biology and biophysical studies, limiting drug discovery programs even when promising…...

1+ week, 5+ day ago  (335+ words) New study reports two-fold improvement in full-to-empty rAAV ratio versus commercial HEK293 line NewBiologix S.A. (Lausanne, Switzerland) has announced the publication of peer-reviewed data in Biotechnology Reports (Vol. 49, March 2026) describing NBX1P01, a clonal HEK293 cell line developed for recombinant adeno-associated virus (rAAV) production. The…...

1+ week, 6+ day ago  (299+ words) Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients What further iterations or applications can we expect from this technology? DM: We are learning every day with this process…...

2+ week, 5+ day ago  (418+ words) Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery'The Medicine Maker Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. - t031.themedicinemaker.com 2 AWSALB [x2]Registers which server-cluster is serving the visitor....

1+ mon, 6+ day ago  (475+ words) New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use Electronic lab notebooks (ELNs) were introduced to modernize laboratory work. But new research from Sapio Sciences suggests many scientists now see them as…...

1+ mon, 1+ week ago  (266+ words) Bringing speed, consistency, and insight to sterile drug inspection Particulate inspection has typically relied on human expertise. While effective, manual inspection is inherently high in volume, highly repetitive and time-consuming. For high volume products, batch sizes can exceed 500,000 vials or…...

1+ mon, 1+ week ago  (399+ words) AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies. The history of technological innovation, from the industrial revolution to the present day, has been…...